The Use of Rivaroxaban for Unprovoked Pulmonary Embolism in the Setting of Antithrombin Deficiency. 2020

Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
Internal Medicine, Des Moines University, Des Moines, USA.

A 24-year-old woman with antithrombin (AT) deficiency presented with right-sided pleuritic chest pain of five days duration with diagnosis of pulmonary embolism (PE) made at an outside hospital. After discussion of treatment options with the patient, her treatment was changed to rivaroxaban protocol. The case illustrates an appropriate treatment plan for patients with AT deficiency presenting with unprovoked PE, especially when prioritizing ease of use.

UI MeSH Term Description Entries

Related Publications

Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
January 2020, Acta haematologica,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
November 2017, Journal of cardiology cases,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
June 2012, The New England journal of medicine,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
June 2012, The New England journal of medicine,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
June 2012, The New England journal of medicine,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
June 2013, Advances in therapy,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
April 2019, Medicine,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
May 2014, The American journal of managed care,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
April 2012, The New England journal of medicine,
Oscar J Gryn, and Trivian Nguyen, and Daniela Frankova
January 2013, Revista clinica espanola,
Copied contents to your clipboard!